Eaton J - Search Results

1

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies.

Pandha HS, Stockwin LH, Eaton J, Clarke IA, Dalgleish AG, Todryk SM, Blair GE. Pandha HS, et al. Among authors: eaton j. Prostate Cancer Prostatic Dis. 2003;6(1):6-11. doi: 10.1038/sj.pcan.4500611. Prostate Cancer Prostatic Dis. 2003. PMID: 12664058

2

Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques.

Eaton JD, Perry MJ, Todryk SM, Mazucco RA, Kirby RS, Griffiths JR, Dalgleish AG. Eaton JD, et al. Gene Ther. 2001 Apr;8(7):557-67. doi: 10.1038/sj.gt.3301432. Gene Ther. 2001. PMID: 11319623

3

The immunotherapy of prostate cancer.

Dalgleish AG, Perry MJ, Eaton JD, Hrouda D, Todryk SM, Kirby RS. Dalgleish AG, et al. Among authors: eaton jd. Prostate Cancer Prostatic Dis. 2000 Dec;3(4):303-307. doi: 10.1038/sj.pcan.4500487. Prostate Cancer Prostatic Dis. 2000. PMID: 12497083

4

The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer.

Eaton JD, Clarke IA, Pandha H, Dalgleish AG, Kirby RS. Eaton JD, et al. Prostate Cancer Prostatic Dis. 2000 Dec;3(S1):S10. doi: 10.1038/sj.pcan.4500449. Prostate Cancer Prostatic Dis. 2000. PMID: 12497120 No abstract available.

5

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.

Todryk SM, Eaton J, Birchall L, Greenhalgh R, Soars D, Dalgleish AG, Melcher AA, Pandha HS. Todryk SM, et al. Among authors: eaton j. Cancer Immunol Immunother. 2004 Apr;53(4):323-30. doi: 10.1007/s00262-003-0452-1. Epub 2003 Nov 28. Cancer Immunol Immunother. 2004. PMID: 14648067 Free PMC article.

6

Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy.

Pandha H, Eaton J, Greenhalgh R, Soars D, Dalgleish A. Pandha H, et al. Among authors: eaton j. Cancer Gene Ther. 2005 Jun;12(6):572-8. doi: 10.1038/sj.cgt.7700836. Cancer Gene Ther. 2005. PMID: 15803141

7

Allogeneic whole-cell vaccine: a phase I/II study in men with hormone-refractory prostate cancer.

Eaton JD, Perry MJ, Nicholson S, Guckian M, Russell N, Whelan M, Kirby RS. Eaton JD, et al. BJU Int. 2002 Jan;89(1):19-26. BJU Int. 2002. PMID: 11849155 Clinical Trial.

8

Urethral wands for impotence.

Bott SR, Eaton JD, Kirby RS. Bott SR, et al. Among authors: eaton jd. BJU Int. 2001 Mar;87(4):411. doi: 10.1046/j.1464-410x.2001.00120.x. BJU Int. 2001. PMID: 11251540 No abstract available.

9

The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.

Oades GM, Eaton JD, Kirby RS. Oades GM, et al. Among authors: eaton jd. Curr Urol Rep. 2000 Aug;1(2):97-102. doi: 10.1007/s11934-000-0043-z. Curr Urol Rep. 2000. PMID: 12084322 Review.

10

Perioperative outcomes of 6042 nephrectomies in 2012: surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database.

Henderson JM, Fowler S, Joyce A, Dickinson A, Keeley FX; BAUS. Henderson JM, et al. BJU Int. 2015 Jan;115(1):121-6. doi: 10.1111/bju.12770. Epub 2014 Jul 27. BJU Int. 2015. PMID: 24725810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,087 results

Search Page

Filters